Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Tattooing Improves Response to DNA Vaccine

By HospiMedica staff writers
Posted on 28 Feb 2008
Tattooing is a more effective way of delivering DNA vaccines than intramuscular injection, reports a new study.

Researchers at the Deutsches Krebsforschungszentrum (German Cancer Research Center, Heidelberg, Germany) examined delivery of a DNA vaccine antigen by tattooing the skin of mice, comparing it with standard intramuscular injection. More...
The researchers used a coat protein from human papillomavirus (HPV, the cause of cervical cancer) as a model and tested it both with, and without, the molecular adjuvants that are often given to boost immune response.

The researchers found that the tattoo method gave a stronger humoral response and cellular response than intramuscular injection, even when adjuvants were included in the latter. Three doses of DNA vaccine that were given by tattooing produced at least 16 times higher antibody levels than three intramuscular injections with adjuvant. The adjuvants enhanced the effect of intramuscular injection, but not of tattooing. The study was published on February 8, 2008, in the online open access journal Genetic Vaccines and Therapy.

"Vaccination with naked DNA has been hampered by its low efficiency,” said lead author Dr. Martin Müller, Ph.D. "Delivery of DNA via tattooing could be a way for a more widespread commercial application of DNA vaccines.”

Tattooing is an invasive procedure done with a solid vibrating needle, causing a wound and sufficient inflammation to ‘prime' the immune system. It also covers a bigger area of the skin than an injection, so the DNA vaccine can enter more cells. These effects may account for the stronger immune response arising from introducing a DNA vaccine into the body by tattooing. The researchers believe that tattooing could have a role in routine vaccination of cattle or in delivering therapeutic (rather than prophylactic) vaccines to humans.


Related Links:
German Cancer Research Center

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.